A 36-Year-Old Woman with End-Stage Renal Disease Secondary to Type

A 36-year-old woman with end-stage renal disease secondary to type 1 diabetes mellitus comes to the office for routine examination.  The patient's medical history includes hypertension, diabetic retinopathy, and neuropathy.  Hemodialysis was started 2 months ago along with an erythropoiesis-stimulating agent.  She takes daily long- and short-acting insulin, lisinopril, and calcitriol.  Her hemoglobin has increased from 7.4 g/dL to 10.2 g/dL over the past 2 months.  Which of the following complications is most likely to be seen with the agent used to treat this patient's anemia?

A) Angioedema
B) Diarrhea
C) Hyperkalemia
D) Hypoglycemia
E) Mineral bone disease
F) Worsening hypertension

Correct Answer:

Verified

Unlock this answer now
Get Access to more Verified Answers free of charge

Access For Free